STEPHEN D. ROBERTS, PH.D.
When the outcome of a clinical trial shows that one treatment increases survival over alternative therapies, the result may be expected to establish a new standard of medical practice, particularly if the trial involves multiple clinical sites with a large number of patients and is conducted by a prominent group of investigators. The trial of continuous versus nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease, reported in this issue (1), may set such a standard of care. The study concludes that patients with hypoxemic chronic obstructive lung disease, particularly those with more severe derangements of lung and brain function
Learn more about subscription options.
Register Now for a free account.
ROBERTS SD. Cost-Effective Oxygen Therapy. Ann Intern Med. 1980;93:499–500. doi: 10.7326/0003-4819-93-3-499
Download citation file:
Published: Ann Intern Med. 1980;93(3):499-500.
Healthcare Delivery and Policy, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only